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Neuroﬁbromatosis 1 - Mutant microglia exhibit sexually-dimorphic cyclic
AMP-dependent purinergic defects
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As critical regulators of brain homeostasis, microglia are inﬂuenced by numerous factors, including sex and
genetic mutations. To study the impact of these factors on microglia biology, we employed genetically engineered mice that model Neuroﬁbromatosis type 1 (NF1), a disorder characterized by clinically relevant
sexually dimorphic diﬀerences. While microglia phagocytic activity was reduced in both male and female heterozygous Nf1 mutant (Nf1+/−) mice, purinergic control of phagocytosis was only aﬀected in male Nf1+/−
mice. ATP-induced P2Y-mediated membrane currents and P2RY12-dependent laser lesion-induced accumulation
of microglial processes were also only impaired in male, but not female Nf1+/−, microglia. These defects
resulted from Nf1+/− male-speciﬁc defects in cyclic AMP regulation, rather than from changes in purinergic
receptor expression. Cyclic AMP elevation by phosphodiesterase blockade restored the male Nf1+/− microglia
defects in P2Y-dependent membrane currents and process motility. Taken together, these data establish a sex-bygenotype interaction important to microglia function in the adult mouse brain.

1. Introduction
The implementation of precision medicine requires the identiﬁcation of the risk factors that underlie disease pathogenesis and progression (Wegscheid et al., 2018; Bennett and Bennett, 2020; Yirmiya
et al., 2015; Wright-Jin and Gutmann, 2019). In the setting of central
nervous system (CNS) disease, microglia have emerged as one of the
key cell types important for modifying pathobiology and integrating
risk factors. As such, microglia serve important functions in the development and evolution of numerous CNS disorders, ranging from
autism to Alzheimer's disease (Wolf et al., 2017; Whitelaw, 2018). In
addition to actively participating in disease pathogenesis, risk factors,
such as the germline mutation (e.g., ApoE status, Krasemann et al.,
2017) and sex (Hanamsagar et al., 2017; McCarthy and Wright, 2017;
Guneykaya et al., 2018), alter microglia function. In this regard, sexually dimorphic diﬀerences in microglia function can impact on CNS

disease development (Vegeto et al., 2020; Kerr et al., 2019; Fisher et al.,
2018; Nissen, 2017).
To explore the impact of germline genetics and sex in the setting of a
common neurodevelopmental disorder characterized by microglia
dysfunction,
we
focused
on
the
monogenic
syndrome,
Neuroﬁbromatosis type 1 (NF1). Caused by germline mutations in the
NF1 gene, children with NF1 are prone to brain tumours, in particular,
optic pathway gliomas (OPGs), and autism, as well as learning disabilities, attention deﬁcits, and motor function delays (Gutmann et al.,
2017). Moreover, some of these CNS phenotypes are sexually dimorphic: whereas autism is more common in male in the general population, this male predominance is dramatically attenuated in children
with NF1 (Morris et al., 2016). Similarly, girls with NF1-OPGs are 3- to
5-times more likely than boys to lose vision from their tumours and
require treatment (Diggs-Andrews et al., 2014b; Diggs-Andrews et al.,
2014a). In Nf1 optic glioma mice, this sex-speciﬁc eﬀect operates at the
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room temperature. Sections were subsequently mounted in Aqua
Polymount on glass slides for analysis.
Images were acquired using a confocal microscope equipped with a
10× objective and LASAF software (Leica TCS SPE, Leica microsystem).
Pictures were taken throughout the entire thickness of the slice by zstacking (3 μm z-step size, 13 steps).
The number of microglia cells per mm2 was quantiﬁed using Fiji
ImageJ software followed by analysis with Cell Proﬁler® automated cell
counter software (https://cellproﬁler.org/). A total of four slices per
brain region and animal were analyzed. Brieﬂy, the desired areas of
interest (brain region) were selected in Image J on the the maximum
intensity z-projection of the confocal scans. Channels were split into
separate TIF images for analysis with a modiﬁed cell proﬁler protocol
(Bloomﬁeld et al., 2018). Microglial cell number was quantiﬁed using
modiﬁed parameters, including typical diameter object sizes between
0.5 and 50, and a lower threshold value of 0.35. For the DAPI channel,
the diameter object size was set to 10–50 (arbitrary units). A further
ﬁlter step that incorporates microglial cell body size was set to 25. Once
extrapolated, the microglia counts in the diﬀerent brain regions, the
average of four independent images, were normalized, based on the
quantiﬁed area in mm2. Data are presented as number of microglia
cells/mm2.

level of microglia, where estrogen binding to the estrogen receptor-beta
on microglia underlies the observed retinal ganglion cell loss, nerve
ﬁbre layer thinning, and visual acuity reduction (Toonen et al., 2017).
To explore additional sex-speciﬁc diﬀerences uncovered by Nf1
mutation, we leveraged Nf1 mutant mice, genetically similar to patients
with NF1 harboring one mutant germline Nf1 allele. We identiﬁed
male-speciﬁc defects in purinergic function, including phagocytosis,
process movement, and ATP induced membrane currents, which result
from impaired cyclic AMP signaling. Collectively, these ﬁndings establish sex-by-genotype microglial abnormalities in the setting of Nf1
mutation.
2. Materials and methods
2.1. Ethics statement
All procedures involving the handling of living mice were performed in strict accordance with the German Animal Protection Law,
and were approved by the Regional Oﬃce for Health and Social
Services in Berlin (Landesamt für Gesundheit und Soziales, Berlin,
Germany, Permit Number T0014/08, X9023/12, X9005/18, A0376/17)
and the Washington University Animal Studies Committee. Adult mice
were euthanized by cervical dislocation or by transcardial perfusion of
PBS or PFA after intraperitoneal injection of pentobarbital (Narcoren,
Merial GmbH, Hallbergmoos, Germany). All eﬀorts were made to
minimize suﬀering.

2.5. Adult microglia cultures
Microglia from (12–16 weeks old) adult mice were prepared as
described previously (Pannell et al., 2016). Brieﬂy, brains obtained
from adult male and female WT and Nf1+/− mice (12–16 weeks) were
freed of blood vessels and meninges, mechanically dissociated, and
digested with trypsin and DNAse. Cells were then plated onto a conﬂuent monolayer of P0-P2 WT astrocytes in 75 cm2 ﬂasks. The feeder
astrocyte layer was depleted of neonatal microglial cells using chlodronate (200 μg/ml) before adding microglia. Mixed adult and neonatal
microglial cultures were maintained in fresh complete DMEM, and the
medium changed every third day, followed by addition of 33% L292conditioned medium at day 7. One week later, cells were shaken oﬀ,
and used for experiments within 24–48 h.

2.2. Mice
Wild type and Nf1+/− (Brannan et al., 1994) mice used in this
study, either bred onto a wild type or MacGreen (Csf1r-eGFP; Sasmono
et al., 2003) C57/BL6 background, were kept under a 12 h/12 h darklight cycle with food and water supply ad libitum, in accordance with
German laws for animal protection.
2.3. Acute brain slice preparation
Acute cortical brain slices were prepared as previously described
(Boucsein et al., 2003). In brief, mice were euthanized by cervical
dislocation, and their brains removed and cooled in ice-cold artiﬁcial
cerebrospinal ﬂuid (aCSF) containing (in mM): 230 Sucrose, 2.5 KCl, 10
MgSO4, 0.5 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10 D-glucose,
pH 7.4; gassed with 95% O2/ 5% CO2. Brains were then mounted on a
vibratome (HM650V, Thermo Scientiﬁc, Massachusetts, USA), and
250 μm thick coronal brain slices were generated and kept at room
temperature for experiments for up to 5 h in gassed ACSF containing (in
mM): 134 NaCl, 2.5 KCl, 1.3 MgCl2, 2 CaCl2, 1.26 K2HPO4, 26 NaHCO3,
and 10 D-glucose (pH 7.4). Acute brain slices were used for patch clamp
recordings and in situ 2-photon live-cell imaging.

2.6. In situ phagocytosis assay
The phagocytosis assay was performed as previously described
(Wendt et al., 2017; Pan et al., 2018). Brieﬂy, 130 μm acute coronal
brain slices from 14 to 16 week-old Nf1+/− mice and their WT littermates (n = 5–6, for AR-C66096 condition n = 2–3) were used.
Brains were sliced in ice-cold ACSF buﬀer solution containing (in mM):
NaCl, 134; KCl, 2.5; MgCl2, 1.3; CaCl2, 2; K2HPO4, 1.25; NaHCO3, 26; Dglucose, 10; pH 7.4; gassed with 95% O2 and 5% CO2 using a vibratome
(HM650V, Thermo Scientiﬁc, Massachusetts, USA). Slices rested for 2 h
at room temperature in ACSF, which was constantly gassed with carbogen (95% O2 and 5% CO2). The slices were subsequently incubated
for 1 h at 37 °C (95% O2 / 5% CO2) with Bright Blue ﬂuorescent carboxylated microspheres (4.5 μm diameter, Polysciences, Hirschberg an
der Bergstraße, Germany) to allow for phagocytosis (with the corresponding chemicals to the included conditions). Prior to incubation,
microspheres were opsonized by shaking in FCS at 1000 rpm for 30 min
at room temperature and centrifuged (2 min at 3000 rpm, Eppendorf
Centrifuge 5417R- Rotor FA45–30-11; rotor radius metric: 9.5 cm),
washed in PBS and resuspended in HBSS. Each brain slice was incubated with 2.45 × 106 microspheres with a 4.5 μm diameter in a
volume of 500 μl HBSS. UDP (100 μM), MRS2578 (5 μM) or AR-C66096
(1 μM) were added to the HBSS-microsphere suspension during the 1 h
incubation period. Brain slices were washed after microsphere treatment 3 × 20 min in 0.1 M PBS at pH 7.4, ﬁxed with 4% PFA for 1 h at
room temperature, and then stored at 4 °C. For staining with Iba1, ﬁxed
slices were incubated for 4 h at room temperature in blocking buﬀer
containing 2% Triton X-100, 2% bovine serum albumin and 10%

2.4. Immunohistochemistry, confocal microscopy and microglial density
analysis
For the immunohistochemical analysis, animals were deeply anesthetized with ketamine, perfused with phosphate buﬀered saline
(PBS) solution, followed by 4% PFA in PBS. Afterwards, mice were
decapitated, and their brains removed and sectioned in the coronal
plane at 40 μm thickness using a sliding dry-iced-cooled microtome.
Free-ﬂoating sections were incubated for 1 h in 5% donkey serum and
0.1% Triton-X in Tris-buﬀered saline solution (TBSplus).
For microglial density analysis, goat anti-Iba1 (Abcam, ab5076)
primary antibody was diluted 1:250 in TBS plus and incubated overnight at 4 °C. The secondary antibody, donkey anti-goat Alexa Fluor
488 (Dianova, 705–545-147), was also prepared in TBS plus at a dilution of 1:200, and cell nuclei were labeled using 4′,6-diamidino-2phenylindole (DAPI, Dianova) at a dilution of 1:200, for two hours at
2
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wavelength of 810 nm and to maximum power in the selected imaging
volume, and scanned the tissue until autoﬂuorescence of the injured
tissue was visible. This procedure resulted in lesions of ~ 20 μm in
diameter in the middle of the observed region. IGOR Pro 6.37 (Lake
Oswego, USA) was used for data analysis as in Davalos et al. (2005).
The sequences of 3D image stacks were converted into sequences of 2D
images by a maximum intensity projection algorithm. Grayscale images
were ﬁrst converted into binary form using a threshold. For quantiﬁcation, microglial response to focal lesion was deﬁned as EGFP+ pixel
count in a proximal circular region 45 μm around the lesion site over
time (Rx(t)). Distal ﬂuorescence of the ﬁrst time point was determined
within a diameter of 45 μm to 90 μm around the lesion site for normalization (Ry(0)). Microglial responses are were represented as R
(t) = (Rx(t)-Rx(0))/Ry(0).

donkey serum in 0.1 M PBS, pH 7.4. First, incubation with goat polyclonal anti-Iba1 antibody (1:600, Abcam, Berlin, Germany) was performed overnight at 4 °C in staining buﬀer (1:10 dilution of blocking
buﬀer in 0.1 M PBS pH 7.4). Slices were incubated with secondary
antibody (1:250 in staining buﬀer; Alexa Fluor 647-labeled donkey
anti-goat antibody; Invitrogen, Karlsruhe, Germany) for 2 h at room
temperature following 3 × 20 min washes in 0.1 M PBS, pH 7.4. Slices
were mounted in Aqua-Poly/Mount (Polysciences). For confocal imaging of microglia and microspheres, cortical view ﬁelds were randomly
chosen within the cortex, 21 μm thick z-stacks at 1.05 μm intervals
beginning from the surface of each slice were acquired. We used a
confocal laser-scanning microscope from Leica (TCS SPE) and a 20× oil
immersion objective. Data analysis to assess microglial phagocytic activity was performed using Imaris 9.1 (Bitplane, Zürich, Switzerland).
The Iba1+ cell volumes of high-resolution SPE confocal microscopy
stacks were 3D surface-rendered after “background subtraction” (1–3
times; 90 μm each) and thresholding using values of 25–40. Detection
of microspheres within the rendered Iba1+ cell volume was performed
automatically by the “split into surface object” plug-in. The phagocytic
index (PI) was calculated by the following equation: nPM*104/VIba1
where nPM is the number of phagocytosed microspheres and VIba1 is the
volume of Iba1 ﬂuorescence in μm3. The student's t-test was used to
compare each condition separately between Nf1+/− and WT groups.

2.9. Microglia isolation by MACS
12–16 week male and female Nf1+/− and WT mice (n = 3 each)
were transcardially perfused with ice-cold Phosphate Buﬀered Saline
(PBS) to harvest the brain. Brains were subsequently homogenized at
0–4 °C in dissection buﬀer (HBSS, 45% glucose, 1 M HEPES) and cell
pellets were resuspended in 25 ml of 22% Percoll (GE Healthcare, Little
Chalfont, UK). The volume of 5 ml PBS was added as a layer on top.
Centrifugation was performed for 20 min at 950 g with medium acceleration and no brakes to remove myelin and debris. Pellets were
resuspended in ice-cold MACS buﬀer and incubated with anti-mouse
CD11b antibodies coupled to magnetic beads (Miltenyi Biotech,
Bergisch Gladbach, Germany) for 15 min at 4 °C. Cells were resuspended in MACS buﬀer and passed through medium-sized MACS
columns (Miltenyi Biotech) attached to a magnet. The ﬂow-through was
discarded and the cells were ﬂushed out of the columns in MACS buﬀer,
collected by centrifugation, and stored at −80 °C for cAMP ELISA or
seeded in a 96 well plate for the cell viability assay.

2.7. Electrophysiological recordings
Conventional patch-clamp ampliﬁers were used (EPC9 and EPC10,
HEKA Elektronik, Lambrecht, Germany). Acute 250 μm coronal brain
slices were prepared from Nf1+/− and wild type mice generated on a
MacGreen background (Sasmono and Williams, 2012) for microglia
identiﬁcation by ﬂuorescence on an epiﬂuorescent microscope. Patch
pipettes were pulled from borosilicate glasses and had resistances of
4–6 MΩ. The following intracellular solution was used (in mM): KCl,
130; MgCl2, 2; CaCl2, 0.5; Na-ATP, 2; EGTA, 5; HEPES, 10 and sulforhodamine 101, 0.01 (Sigma Aldrich,) and had an osmolarity of
280–290 mOsm/L adjusted to a pH of 7.3 with KOH. The extracellular
solution contained (in mM): NaCl, 134; KCl, 2.5; MgCl2, 1.3; CaCl2, 2;
K2HPO4, 1.25; NaHCO3, 26; D-glucose, 10; pH 7.4; 310–320 mOsm/L
and was gassed with carbogen (95% O2/ 5% CO2). Experiments with
series resistances less than ~65 MΩ were used for data analysis. All
experiments were performed in the voltage-clamp conﬁguration. To
obtain current-voltage curves during continuous recordings, the membrane was clamped every 5 s from a holding potential of −70
or − 20 mV (basal current and ATP-induced current, respectively) to a
series of de- and hyperpolarizing voltages ranging from −140 mV to
60 mV with 20 mV increment, 100 ms in duration. Membrane currents
were averaged for quantiﬁcation between 30 and 45 ms after clamping
the membrane to a given value from the resting potential. Membrane
capacitance was quantiﬁed based on an exponential ﬁt of the current
decay in response to a − 10 mV test pulse. The same pulse was used to
quantify series resistance from the peak amplitude of the membrane
capacitance currents. Comparisons of membrane currents between
diﬀerent groups were always normalized to the membrane capacitance.

2.10. RT-qPCR
Total RNA was extracted from acutely isolated microglia by MACS
using ReliaPrep RNA Miniprep System (Promega, Madison, Wisconsin,
USA). cDNA synthesis was performed using the PrimeScript™ RT reagent Kit (Takara, Kusatsu, Shiga, Japan). Quantitative real-time PCR
reactions to amplify 1 ng of total cDNA were performed in a 7500 Fast
Real-Time thermocycler (Applied Biosystems, Carlsbad, USA) using the
SYBR Select Master Mix (Applied Biosystems). CT values were normalized using Hypoxanthin-Guanin-Phosphoribosyl-Transferase 1
(hprt1) as housekeeping gene. Primers were tested for their eﬃciency
beforehand, and the ΔΔCt-method was applied for analysis of relative
expression. To ensure the speciﬁcity of the PCR product, we analyzed
the melting curves of each product. Primer sequences were as follows
(gene: forward primer, reverse primer); Hprt1: GATTAGCGATGATGAA
CCAGGTT, CCTCCCATCTCCTTCATGACA; P2ry6: GCTGTGTCAGAGGG
AGTTTT, TGTCAGCCTTTCCTATGCTCG; P2ry12: GCACGGACACTTTC
CCGTAT, GCCTTGAGTGTTTCTGTAGGGTA; Tlr2: GACGACTGTACCCT
CAATGG, TTAAATGCTGGGAGAACGAG; Tlr4: AGACCTCAGCTTCAAT
GGTG, GAGACTGGTCAAGCCAAGAA; Tlr7: ATGTGGACACGGAAGAG
ACAA, GGTAAGGGTAAGATTGGTGGTG.

2.8. Two-photon imaging and laser lesioning
Live imaging of microglial processes was performed on 250 μm
coronal brain slices from Nf1+/− mice and their WT littermates
maintained on a MacGreen background (Sasmono and Williams, 2012)
using a custom-built two-photon laser-scanning microscope (Till Photonics, Gräfelﬁng, Germany). EGFP was excited by a Chameleon Ultra II
laser (Coherent, Dieburg, Germany) at a wavelength of 940 nm. A 40×
water-immersion objective (NA 0.8, Olympus, Hamburg, Germany) was
used, with scanned 60 μm thick z-stacks and a step size of 3 μm covering a ﬁeld of 384 × 384 μm2. Laser lesions were set to 40 μm under
the slice surface in the cortex by focusing the laser beam, set to a

2.11. Multiplex immune assay
Cytokine detection was performed using the mouse High Sensitivity
5−plex Multiplex Immunoassay (Thermoﬁsher Scientiﬁc, Waltham,
MA, USA) on microglial cell supernatants collected following stimulation with LPS (100 ng/ml), Pam2CSK4 (100 ng/ml) or Loxoribine
(1 mM) for 24 h, according to the manufacturer's recommendations.
This magnetic bead-based assay enables the simultaneous detection and
quantiﬁcation of multiple proteins in a single sample. Prior to incubation, samples were vortexed followed by centrifugation to remove
3
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Table 1). Similar results were obtained when the density of microglia
was quantiﬁed. In addition, microglial morphology (ramiﬁed versus
amoeboid appearance) was not diﬀerent between groups.

particles. Protein detection was performed on a multiplexing plate
reader (Luminex 200, R&D Systems, Minneapolis, USA) and analyzed
using Bioplex System Software 4.0 (Bio-Rad, Hercules, CA, USA).
Cytokines analyzed included IL-6, TNF-α, IFN- γ, IL-2 and IL-4.
Expression levels are shown as Fluorescent Intensity (FI).

3.2. Cytokine release following toll-like receptor stimulation is not diﬀerent
between microglia from male and female WT and Nf1+/− mice

2.12. cAMP ELISA

Toll-like receptors (TLRs) are expressed on microglia, where they
recognize pathogen-associated molecules, like bacterial and viral
components. Upon activation, TLR signaling culminates with the production of inﬂammatory molecules. To characterize TLR responses, we
generated microglial cultures from adult (12–16 weeks) male and female WT and Nf1+/− mice, and stimulated them for 24 h with LPS,
LOX or Pam2CSK4 to activate TLR4-, TLR7- and TLR2-mediated pathways, respectively. The release of TNF-α, IL-6, IL-2, IL-4 and IFN-γ was
then measured from the culture supernatants using a multiplex ELISA
immunoassay. No diﬀerences between microglial cultures from male
and female WT and Nf1+/− mice were detected (Suppl. Fig. 2), indicating that these inﬂammatory responses were not impacted by either
sex or Nf1 mutation. Consistent with these ﬁndings, no diﬀerences in
microglial Tlr2, Tlr4 and Tlr7 expression were observed between male
and female WT and Nf1+/− mice (Suppl. Fig. 4).

cAMP levels were determined using the cyclic AMP ELISA Kit
(Biomol, Hamburg, Germany) according to the manufacturer's instructions. Brieﬂy, MACS-isolated microglia were diluted in 50 μl HCl
(0.1 M) and centrifuged for 10 min at 1000 g. Supernatant was diluted
in 100 μl ELISA buﬀer to neutralize the acid. Sample acetylation was
performed by adding 30 μl KOH (4 M) and 7.5 μl acetic anhydride,
vortexing for 15 s and adding 7.5 μl KOH (4 M). Samples and standards
were pipetted into the ELISA plates and incubated for 18 h at 4 °C
before the plate was developed with Ellmann's reagent. Fluorescence
was measured at 420 nm using a plate reader (Luminex 200, R&D
Systems, Minneapolis, USA).
2.13. Cell viability assay
Cell viability was evaluated using the CellTiter-Glo® Luminescent
Cell Viability Assay Kit (Promega, Walldorf, Germany) according to the
manufacturer's instructions. Brieﬂy, 2 × 104 MACS-isolated microglia
(in 100 μl PBS) were seeded into each well of a 96 well plate, followed
by the addition of 100 μl CellTiter Glo® reagent and vertical shaking for
10 min at 4 °C. Luminescence was determined using a luminescence
plate reader (Luminex 200, R&D Systems, Minneapolis, USA) after a
30 min incubation at room temperature. Three animals were used for
each condition (male and female WT and Nf1+/−), and three technical replicates were generated.

3.3. Phagocytic activity is reduced in Nf1+/− mice
Phagocytosis is an important function of microglia that enables
them to control synaptic density and plasticity, as well as to maintain
brain homeostasis under inﬂammatory conditions. To assay microglial
phagocytic activity, we employed cortical slices from male and female
Nf1+/− and WT mice between 14 and 16 weeks of age (Wendt et al.,
2017). Phagocytic activity was quantiﬁed by incubating the slices for
60 min with latex beads, and counting the number of beads incorporated into a 3D-rendered Iba1-labeled (microglia) volume using
confocal imaging and 3D reconstruction (Fig. 1 A). Per animal and
condition, we quantiﬁed microglial phagocytosis in 4–5 cortical brain
slices, analyzing 4–5 randomly chosen ﬁelds of view per slice by zstacks (cortex layers I–VI; 5–6 female and 5–6 male WT and Nf1+/−
mice each; 2–3 mice for AR-C66096 treatment, Fig. 1 A). As shown in
Fig. 1 B, baseline microglial phagocytosis was not signiﬁcantly diﬀerent
between female and male WT mice (male WT: 1.76 ± 0.12, n = 69
cells; female WT: 1.82 ± 0.13, n = 83 cells; p = .7220), consistent
with a previous study from our laboratory (Guneykaya et al., 2018). In
striking contrast, microglia from both male and female Nf1+/− mice
displayed reduced phagocytic activity relative to WT mice (male Nf1+/
−: 1.29 ± 0.09; n = 78 cells; p = .0026 vs male WT; female Nf1+/
−: 1.43 ± 0.11; n = 66 cells; p = .0209 vs female WT), indicating an
Nf1-dependent decrease in microglial phagocytosis.

2.14. Statistics
All data are expressed as mean ± SEM. A combination of one-way
ANOVA tests with Tukey post hoc tests were employed to compare data
between the four experimental groups. Signiﬁcance is always given as
*** p < .001, ** p < .01, * p < .05, n.s. p > .05.
3. Results
3.1. Microglia density and morphology are not altered by sex or Nf1
mutation
To determine whether Nf1 mutation or sex alters cellular and/or
microglia content in the brain, we ﬁrst determined the density of microglia in cortex, hippocampus (CA2–3 region), subgranular zone (SGZ)
and amygdala from male and female Nf1+/− and WT mice. Using
DAPI to detect the total number of cells, we found no diﬀerences in
cellular densities with respect to sex or Nf1 mutation (Suppl. Fig. 1 and
Table 1
Cellular and microglial densities in diﬀerent brain regions. (n = number of mice).
Brain region

Ctx
HC
SVZ
Amy
Ctx
HC
SVZ
Amy

M WT

M Nf1

F WT

F Nf1

p value (ANOVA)

cells/mm2

n

cells/mm2

n

cells/mm2

n

cells/mm2

n

2773.2 ± 215.8
3075.9 ± 89.3
2917.1 ± 70.7
3960.8 ± 182.4
microglia/mm2
250.3 ± 31.6
199.8 ± 22.7
169.1 ± 35.6
321.7 ± 20.8

8
9
9
8
n
7
9
9
6

3207.8 ± 142.0
3129.5 ± 92.4
2973.9 ± 43.3
3847.4 ± 110.1
microglia/mm2
267.5 ± 26.2
212.9 ± 20.7
116.0 ± 12.8
321.6 ± 32.9

9
9
9
8
n
9
9
9
8

2913.4 ± 276.7
3063.9 ± 38.6
2754.3 ± 66.6
3920.4 ± 86.3
microglia/mm2
179.5 ± 16.9
147.2 ± 17.9
103.9 ± 23.2
261.2 ± 22.5

9
9
9
8
n
9
9
9
2

2895.0 ± 246.9
3178.0 ± 58.2
2855.4 ± 62.7
4178.4 ± 108.5
microglia/mm2
225.4 ± 30.3
174.5 ± 33.5
103.7 ± 23 7
297.8 ± 26.6

10
10
10
8
n
9
10
10
8

4

0.6005
0.6574
0.1007
0.4561
0.5034
0.2867
0.2279
0.3514
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Fig. 1. Impaired phagocytic activity of microglia from Nf1+/− mice.
A: Representative confocal image (left) of Iba1-stained microglia (red) together with latex beads (blue) performed on brain slices from a representative 13-week-old
WT male mice. Right, 3D reconstructions of Iba1-positive microglia are shown with automatically counted phagocytosed beads (shown in black and indicated by
arrows). Scale bars, 50 μm.
B: Comparison of baseline phagocytic index of cortical microglia reveals lower levels in male and female Nf1+/− mice.
C: Control of microglial baseline phagocytosis by the P2ry6 and P2ry12 purinergic receptors. Blockade of P2ry6 by MRS2578 (5 μM) reduced baseline phagocytosis in
all four groups (male and female WT and Nf1+/− mice). Blockade of P2ry12 by AR-C66096 (1 μM) decreased microglial baseline phagocytosis only in male WT,
female WT, and female Nf1+/− mice, but not in male Nf1+/− mice.
D: P2ry6-mediated stimulation of microglial phagocytosis is dependent on sex or Nf1 mutation. Phagocytosis in the presence of the P2ry6 agonist UDP (100 μM), the
P2ry6 antagonist MRS2578 (5 μM), and UDP + MRS2578 are indicated. UDP-mediated stimulation of phagocytosis in all groups (male and female WT and Nf1+/−
mice) was blocked by MRS2578, indicating that P2ry6 signaling is unaﬀected by sex or Nf1 mutation.
The signiﬁcance levels above the bars indicate the comparisons between WT and Nf1+/− mice; *** p < .001, ** p < .01, * p < .05, n.s. p > .05. Numbers in the
bars indicate the number of analyzed viewﬁelds. Data were obtained from 3 to 9 mice and 12–36 slices per condition. (For interpretation of the references to colour in
this ﬁgure legend, the reader is referred to the web version of this article.)

members of the metabotropic P2Y and ionotropic P2X receptor families.
We have previously shown that microglial membrane current responses
upon application of low (10 μM) ATP concentrations largely depend on
P2RY12 activation (Elmadany et al., 2020), which activates K+ currents through THIK-1 (Wendt et al., 2017; Boucsein et al., 2000;
Boucsein et al., 2003; Madry et al., 2018; Guneykaya et al., 2018). We
analyzed purinergic P2RY12 responses of microglia in acute cortical
slices from 14 to 16 week old male and female Nf1+/− mice using
standard whole-cell patch clamp techniques in the voltage-clamp conﬁguration. The microglial cells in each slice were identiﬁed by ﬂuorescence labeling in WT and Nf1+/− mice intercrossed with MacGreen
(Csf1r-GFP) mice. Consistent with previous studies, WT microglia responded to 10 μM ATP with the induction of an outwardly rectifying
current that reversed close to the equilibrium potential for potassium.
We determined the speciﬁc conductance between +20 mV
and +60 mV to compare these currents in male and female microglia.
The conductance of microglial ATP-evoked potassium currents was
27.0 ± 4.6 pS/pF and 25.4 ± 5.2 pS/pF for male and female WT
microglia, respectively (n = 21 and n = 19 cells, respectively;
p = .8201, Fig. 2 A, B). Similar to the microglia phagocytosis results,
these microglial purinergic responses were reduced in male Nf1+/−
mice (15.7 ± 2.5 pS/pF; n = 36 cells; p = .0234 vs. male WT), indicating an Nf1-dependent impairment. In contrast, 10 μM ATP responses of female Nf1+/− microglia (23.3 ± 5.9 pS/pF; n = 16 cells;
p = .9671) were not diﬀerent from WT females, indicating a sexually
dimorphic impairment of P2RY12 signaling in the setting of an Nf1
mutation.

3.4. Purinergic signaling alters microglial phagocytic activity in a sex- and
Nf1-dependent manner
It is well established that purinergic signaling controls microglial
phagocytosis, speciﬁcally through the purinergic receptors, P2RY6
(Koizumi et al., 2007; Xu et al., 2016; Wendt et al., 2017) and P2RY12
(Diaz-Aparicio et al., 2020). To examine the eﬀect of purinergic signaling on basal phagocytic activity in Nf1-mutant microglia, we evaluated P2RY6 and P2RY12 receptor signaling using receptor-speciﬁc
inhibitors (MRS2578, 5 μM and AR-C66096, 1 μM, respectively) (Fig. 1
C). MRS2578 reduced the phagocytic activity of microglia to a similar
level in all groups, male and female WT and Nf1+/−, suggesting that
Nf1-dependent reduction in basal phagocytosis of both sexes (Fig. 1 B)
is likely due to P2RY6-dependent mechanisms. However, treatment
with the P2RY6 ligand UDP (100 μM), enhanced phagocytosis in all of
the four groups (Fig. 1 D, Table 2) indicating that there was no general
failure in P2RY6 signaling in male and female Nf1+/− microglia. This
conclusion is also supported by our ﬁnding that there were no diﬀerences in P2ry6 mRNA levels between male and female WT and Nf1+/
− microglia (Suppl. Fig. 4).
P2RY12 inhibition reduced microglial phagocytosis similar to that
observed following P2RY6 blockade in male and female WT mice (Fig. 1
C, Table 2). Relative phagocytic activities in the presence of AR-C66096
were 0.80 ± 0.10 for male WT microglia (p < .001 vs. control and
p = .1676 vs. MRS2578) and 1.26 ± 0.16 for female WT microglia
(p < .001 vs. control and p = .1635 vs. MRS2578). Interestingly, ARC66096 did not decrease basal microglial phagocytosis in Nf1+/−
male mice (1.12 ± 0.11, n = 52; p = .2256 vs male Nf1+/− control),
indicating a reduced contribution of P2RY12 signaling to baseline
phagocytic activity. In female Nf1+/− mice, AR-C66096 reduced
microglial phagocytic activity similar to female WT mice (1.03 ± 0.14,
n = 27; p = .0291 vs female Nf1+/− control). Taken together, the
P2RY12-mediated microglia phagocytosis is altered in a sexually dimorphic fashion in the setting of a heterozygous Nf1 mutation.

3.6. P2X-dependent purinergic membrane currents are not altered in
Nf1+/− mice
To analyze P2X receptor signaling, we measured microglial membrane currents evoked by the application of 1 mM ATP (Fig. 2 C, D), a
concentration suﬃcient to activate P2RX7, the most common P2X receptor isoform in microglia (Butovsky et al., 2014; Ousingsawat et al.,
2015). 1 mM ATP application induced large membrane currents within
the application period (60 s), which were characterized by an inward
and outward component and a reversal potential close to 0 mV, consistent with the characteristics of the non-selective cation channel

3.5. P2RY-dependent microglia membrane currents are impaired in male
Nf1+/− mice
Microglia express a variety of purinergic receptors, including
Table 2
Purinergic receptors regulate microglia phagocytosis.
Condition

♂ WT

♂ Nf1
3

control
UDP
UDP &
MRS2578
MRS2578
AR-C66096

3

♀ WT
3

3

♀ Nf1

engulfed beads*10 /μm

n

engulfed beads*10 /μm

n

engulfed beads*10 /μm

n

engulfed beads*103/μm3

n

1,76 ± 0,12
2,30 ± 0,14
1,68 ± 0,13

69
81
81

1,29 ± 0,09
1,74 ± 0,12
1,38 ± 0,09

78
73
60

1,82 ± 1,13
3,18 ± 0,22
1,69 ± 0,14

83
84
84

1,43 ± 0,11
2,17 ± 0,22
1,24 ± 0,08

66
77
73

0,99 ± 0,10
0,80 ± 0,10

86
51

0,98 ± 0,08
1,12 ± 0,11

75
52

1,00 ± 0,09
1,26 ± 0,16

65
43

1,02 ± 0,08
1,03 ± 0,14

64
27

6

3

3
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Fig. 2. Nf1-dependent alterations in microglial purinergic membrane current responses.
A and C: Representative patch-clamp recordings from male and female WT and Nf1+/− microglia. From a holding potential of −20 mV, cells were repetitively
clamped at a series of potentials between −140 and +60 mV every 5 s. Application of 10 μM ATP (A) or 1000 μM ATP (C) is indicated by the bars. Note the typical
metabotropic purinergic response to 10 μM ATP with activation of outwardly rectifying currents (A) and the typical P2X-like induction of a cationic conductance
upon 1000 μM ATP (C) exposure.
B and D: Averaged current density-voltage relationships of currents evoked by 10 μM ATP (B) or 1000 μM ATP (D). Current responses were obtained by subtraction of
microglial membrane currents prior to and in the presence of 10 μM (B) or 1000 μM (D) ATP, followed by normalization to the capacitance.
Male Nf1+/− mice displayed signiﬁcantly smaller metabotropic purinergic responses (ANOVA/Tukey). Number of recorded cells (mice): male WT, 26 (12); male
Nf1+/−, 29 (14); female WT, 19 (11); female Nf1+/−, 16 (10).
There were no signiﬁcant sex- or Nf1-dependent diﬀerences in P2X-like currents (ANOVA/Tukey).
Number of recorded cells (mice): male WT, 13 (9); male Nf1+/−, 14 (11); female WT, 7 (6); female Nf1+/−, 12 (9).

(Fig. 2 C). The speciﬁc conductance between −100 mV and − 140 mV
was quantiﬁed to compare P2X-like currents in male and female WT
microglia. Conductances were 102.1 ± 18.2 pS/pF (n = 13 cells) and
122.8 ± 44.1 pS/pF (n = 7 cells) for male and female WT microglia,
respectively (p = .6150). P2X receptor-like currents in cortical microglia from male and female Nf1+/− mice were similar to their WT
counterparts (89.9 ± 21.0 pS/pF; n = 14 cells; p = .6678 for male and
114.7 ± 36.4 pS/pF; n = 12 cells; p = .8920 for female), demonstrating that the Nf1 mutational and sexually dimorphic diﬀerences in
microglia purinergic signaling were speciﬁc to metabotropic P2Y receptor signaling.

Materials and Methods; Fig. 3 A). The response of male WT microglia
30 min after the laser lesion was 0.043 ± 0.004 (n = 21 cells), which
was greater than observed in female WT microglia (0.027 ± 0.002;
n = 26 cells; p = .0014). No translocation of microglial cell bodies was
seen during the observation period. In contrast, whereas female Nf1+/
− microglia exhibited no diﬀerences (0.021 ± 0.003; n = 20 cells;
p = .4798) relative to their WT counterparts, process extension in male
Nf1+/− microglia was decreased to 0.015 ± 0.002 (n = 20 cells;
p < .0001) relative to male WT controls.

3.7. Basic membrane properties of microglia are not Nf1-dependent

To determine the basis for the sexual dimorphism in microglia
purinergic signaling observed in male Nf1+/− mice, we ﬁrst examined
P2RY6 and P2RY12 mRNA expression in acutely isolated microglia
from adult mouse brains (14–16 weeks). Following MACS (CD11b)
isolation, qPCR using P2RY6- and P2RY12-speciﬁc primers (Suppl.
Fig. 4) revealed no diﬀerences in mRNA expression between male and
female WT and Nf1+/− microglia, excluding receptor expression levels as the causative etiology for the diﬀerences in purinergic signaling.
Next, we examined intracellular cAMP levels, based on prior studies
in astrocytes (Dasgupta et al., 2003; Anastasaki and Gutmann, 2014)
and the fact that purinergic signaling results in increased cAMP generation (Post et al., 1996; Post et al., 1998). Microglia were isolated
from whole brains of male and female WT and Nf1+/− mice
(12–16 weeks) by MACS using CD11b antibodies, and subjected to
ELISA to measure intracellular cAMP levels (Fig. 4 A). We ﬁrst performed a cell viability assay on MACS-isolated microglia from the four
groups and excluded potential sex- or genotype-dependent diﬀerences
in microglial persistence to the MACS isolation procedure (Suppl.
Fig. 5). cAMP levels were similar in female (1.8 ± 0.3 pg/ml, n = 3
mice) and male (2.5 ± 0.1 pg/ml; n = 3 mice; p = .1772) WT microglia, however, reduced microglial cAMP levels were observed in
male Nf1+/− (1.4 ± 0.3 pg/ml, n = 3 mice) relative to WT
(p = .0301) microglia (Fig. 4 B). In contrast, female Nf1+/− microglia
(1.7 ± 0.1 pg/ml, n = 3 mice) did not diﬀer from WT controls
(p = .9950), indicating that microglial cAMP levels are aﬀected by Nf1
mutation in a sexually-dimorphic manner.

3.9. Microglial cAMP levels are reduced in male Nf1+/− mice

Consistent with previous data from our laboratory and others (see
Kettenmann et al., 2011), microglia from 14 to 16 week old WT mice
display characteristic membrane currents when repetitively clamped at
potentials between −170 and +60 mV, starting from a holding potential of −70 mV. Microglia are characterized by a high input resistance and a small inwardly rectifying conductance between −40
and − 170 mV (Suppl. Fig. 3 A, B). The reversal potential, indicative of
the resting membrane potential, was −27.7 ± 1.2 mV (n = 27 cells)
and − 29.2 ± 2.2 mV (n = 23 cells) for male and female WT microglia, respectively (p = .5435), as previously described (Guneykaya
et al., 2018). The apparent membrane capacitance was not diﬀerent
between the two sexes, with microglia from male WT mice having
21.0 ± 1.2 pF (n = 27 cells) and from female WT mice 23.2 ± 1.3 pF
(n = 11 cells; p = .2272; Suppl. Fig. 3 C, D). However, in contrast to
our previous study (Guneykaya et al., 2018), the amplitude of the inwardly rectifying currents were not signiﬁcantly diﬀerent between male
and female WT microglia (p = .2508). This could be potentially explained by diﬀerences in the mouse strains used in these two studies.
Additionally, cortical microglia from Nf1+/− mice did not diﬀer from
their WT counterparts with respect to reversal potentials (male Nf1+/
−: n = 47 cells; p = .1589 vs WT; female Nf1+/−: n = 37 cells;
p = .3385 vs WT) and capacitance (male: p = .9342; female:
p = .3553). Inwardly rectifying currents were also not diﬀerent between male (p = .0681) or female (p = .0754). WT and Nf1+/−
microglia. Taken together, there are no sex-dependent diﬀerences in the
electrophysiological proﬁles of cortical microglia in normal mice or in
the setting of an Nf1 mutation.

3.10. Increasing intracellular cAMP levels rescues male Nf1+/− microglia
phenotypes
To restore intracellular cAMP levels in microglia, we took advantage
of the preferential expression of the phosphodiesterase (PDE) 3B subtype in microglia, and used cilostamide, a selective PDE3 inhibitor, to
increase cAMP levels in microglia in situ (Bernier et al., 2019). Treatment with 10 μM cilostamide for 10 min resulted in a normalization of
ATP-(10 μM) induced outward currents in microglia from male Nf1+/
− mice similar to levels observed in WT male microglia (Fig. 4 C, D). In
addition, cilostamide treatment also ameliorated the male Nf1+/−
microglia defect in directed process movement towards a laser lesion.
Pretreatment of slices with 10 μM cilostamide for 10 min partly corrected the movement defect in male Nf1+/− microglia (Fig. 4 E, F).
Taken together, these data establish that the sexually dimorphic Nf1+/

3.8. Microglial process extension is impaired in male Nf1+/− mice
Another P2RY12-mediated function in microglia is process extension in response to injury (Haynes et al., 2006; Madry et al., 2018;
Guneykaya et al., 2018), where microglia respond with targeted
movement of their processes towards the lesion site (Nimmerjahn et al.,
2005; Davalos et al., 2005). Microglial responses in acute brain slices of
adult (13–15 weeks) male and female WT and Nf1+/− mice on a
MacGreen background were analyzed following a laser lesion by twophoton imaging. The movement of microglial processes was quantiﬁed
by determining the ﬂuorescence distribution within the area of concentric circles (45 μm and 90 μm) around the lesion site (for details, see
8
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Fig. 3. Injury-directed process movement activity is decreased in male Nf1+/− microglia.
A: Representative pictures of injury-induced process movement of EGFP-positive microglia in the cortex of acute brain slices from male and female WT and Nf1+/−
mice. Acute injury was induced by a focal laser lesion (left images) and microglial movement activity was recorded for 30 min (right images). Yellow lines indicate
the concentric circles (solid: 45 μm; dotted: 90 μm) around the lesion site used for oﬄine quantiﬁcation of microglial process movements.
B: Quantitative analysis of lesion-induced, microglial process movement expressed in arbitrary units (AU) in male and female WT and Nf1+/− mice. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Male Nf1+/− microglia displayed signiﬁcantly weaker process responses than male WT microglia. Number of experiments (and mice): male WT, 21 (9); male
Nf1+/−, 20 (6); female WT, 26 (9); female Nf1+/−, 20 (6).

− microglia purinergic signaling defects result from alterations in intracellular cAMP levels.

leading to impaired phagocytosis, process movement, and membrane
currents. These observations fortify prior observations that male microglia contribute diﬀerentially to brain pathology. For example,
P2RX4 is uniquely induced in male microglia after injury (Sorge et al.,
2015), resulting in male pain hypersensitivity. Similarly, male, but not
female, microglia exhibit ATP-dependent p38-MAPK phosphorylation
and brain-derived neurotrophic factor (BDNF) release (Mapplebeck

4. Discussion
In this report, we demonstrate that sex and genotype interact to
result in male-speciﬁc defects in microglial purinergic signaling,
9
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(caption on next page)

The role of cAMP in microglia ramiﬁcation and process movement
has previously been shown using PDE inhibitors and G protein-coupled
receptor activation (Bernier et al., 2019). In addition, norepinephrinedependent changes in microglial morphology and function in awake
and anesthetized mice are cAMP dependent (Stowell et al., 2019; Liu
et al., 2019). In the setting of Nf1 mutation, the Nf1 protein (neuroﬁbromin) controls cAMP homeostasis in human and mouse neurons
through RAS-mediated activation of an atypical Protein Kinase-C
(PKCζ), resulting in reduced G protein-coupled receptor stimulation of

et al., 2018). While these sex diﬀerences could reﬂect the diﬀerential
expression of purinergic receptors (e.g., P2RX4, P2RX7, P2RY12) in
male microglia (Guneykaya et al., 2018), this was not the etiology for
the sex-by-genotype eﬀects observed in male Nf1-mutant microglia.
Instead, we discovered that cAMP diﬀerences in male Nf1+/− microglia underlie these sexually dimorphic phenotypes in young adult
mice (12–16 weeks of age). As age aﬀects microglial function and sex
diﬀerences throughout lifespan, these sex by genotype eﬀects might be
diﬀerent in older or younger mice.
10
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Fig. 4. Decreased cAMP levels in male Nf1+/− microglia determine their functional impairments.
A and B: Intracellular cAMP levels are decreased in male Nf1+/− microglia. A, Scheme representing the procedure for determining microglial cAMP levels in male
and female WT and Nf1+/− mice. Microglia were MACS-isolated (CD11b) from whole brains in the cold (0–4 °C), and then prepared for commercial ELISA (see
methods). B, While there were signiﬁcant diﬀerences in cAMP levels between male WT and Nf1+/− microglia, no diﬀerences were observed between female WT
and Nf1+/− microglia.
C and D: Cilostamide restores impairments in P2RY12-dependent membrane responses. C, Representative patch-clamp recordings from male Nf1+/− microglia.
From a holding potential of −20 mV, cells were repetitively clamped at a series of potentials between −140 and + 60 mV every 5 s. Application of 10 μM ATP is
indicated by the bars. Note that the decrease in typical metabotropic purinergic responses upon 10 μM ATP with an activation of outwardly rectifying currents was
restored by cilostamide (10 μM) treatment. D, Averaged current density-voltage relationships of currents evoked by 10 μM ATP in the presence or absence of
cilostamide. Current responses were obtained by subtraction of microglial membrane currents prior to and in the presence of 10 μM ATP and subsequent normalization to the capacitance.
E and F: Impaired directed process movement in male Nf1+/− microglia is restored by cilostamide treatment. E, Representative images of injury-induced process
movement of EGFP-positive microglia in the cortex of acute brain slices from male Nf1+/− mice in the presence of 10 μM cilostamide. Acute injury was induced by a
focal laser lesion (left images), and microglial responses were observed for 30 min (right images). Yellow lines indicate the concentric circles (normal: 45 μm; dotted:
90 μm) around each lesion site used for oﬄine quantiﬁcation of microglial process movements. F, Quantitative analysis of lesion-induced, microglia process
movement in male WT and Nf1+/− mice. Note the rescue of process movement in male Nf1+/− microglia following cilostamide treatment; one-way ANOVA and
Tukey tests were performed. N = 9 experiments (4 mice) for cilostamide-treated slices. (For interpretation of the references to colour in this ﬁgure legend, the reader
is referred to the web version of this article.)

services provided by the Advanced Light Microscopy facility (MDC,
Berlin).

adenylyl cyclase (Anastasaki and Gutmann, 2014). However, it is not
known how neuroﬁbromin regulates cAMP homeostasis in microglia or
whether the observed sexual dimorphic eﬀects involve gonadal sex
hormone or sex chromosome diﬀerences (Arnold, 2009), microbiome
inﬂuences (Thion et al., 2018) or the diﬀerential expression of regulatory microRNAs (Kodama et al., 2020).
In patients with NF1, impulsivity and hyperactivity is more common
in boys than girls (Cohen et al., 2018), and, as seen in the general population, there is a male bias in the prevalence of autism spectrum
disorders (ASD) in children with NF1 (Garg et al., 2016). In this regard,
previous studies from our laboratory demonstrated that male, but not in
female, Nf1+/− mice exhibit reduced hippocampal dopamine levels,
increased RAS/ERK activity, and impaired spatial learning (DiggsAndrews et al., 2014b). In the current study, we investigated microglial
cells, which are, particularly during early postnatal stages, critical for
the development and homeostasis of neuronal networks, mainly due to
their ability to prune synapses (Tremblay et al., 2011; Kettenmann
et al., 2013; Bilimoria and Stevens, 2015; Michell-Robinson et al.,
2015). As such, there is growing evidence for a crucial role of microglia
in the development psychiatric disorders including schizophrenia
(Mattei et al., 2014) and ASD (Petrelli et al., 2016). Since no direct
evidence exists for such a causal link in the setting of NF1, future studies will be required to elucidate the impact of reduced microglial
P2RY12 activity on social interaction phenotypes in male and female
Nf1-mutant mice.
Taken together, the ﬁnding of sexually dimorphic diﬀerences in
microglia harboring a germline Nf1 mutation adds to the growing
number of sex-speciﬁc abnormalities described in microglia, including
diﬀerences in morphology (Lenz et al., 2013), function (Nelson et al.,
2017), and density (Schwarz et al., 2012; Vanryzin et al., 2019). In
addition, male and female microglia also have diﬀerent rates of transcriptional maturation and immune reactivity (Hanamsagar et al.,
2017; Guneykaya et al., 2018). Some of these diﬀerences may be “hard
wired” by sex, given that female microglia oﬀer protection in the face of
ischemic injury when transplanted into male brains (Villa et al., 2018).
Understanding how these sex diﬀerences are established and maintained will provide new insights into our understanding of the interplay
between risk factors and cellular function in the brain.
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